Stocks · News reference
Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’
CNBC traders picked WST, JPM, META and IYE; analysts raised WST and META targets, while JPM missed Q3 earnings and revenue estimates.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
JPMorgan Analysts Boost Their Forecasts After Q3 Results
JPMorgan misses Q3 earnings and revenue estimates; shares dip 1.3% as analysts lift price targets and company forecasts 2027 NII growth.
Meta To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts raised targets for ACI, ORIC, JPM, SHOP, META and U; KTB upgraded to Buy. Domino’s target was cut.
Morgan Stanley Maintains Equal-Weight on JPMorgan Chase, Raises Price Target to $377
Morgan Stanley analyst Manan Gosalia maintains JPMorgan Chase (NYSE:JPM) with a Equal-Weight and raises the price target from $370 to $377.
Baird Maintains Neutral on JPMorgan Chase, Raises Price Target to $312
Baird analyst David George maintains JPMorgan Chase (NYSE:JPM) with a Neutral and raises the price target from $305 to $312.
Wall Street’s ‘Last Men Standing’: The Mag 7 Are Propping Up the S&P 500, Then Why Are Your ETFs at Risk?
The Mag 7 are propping up the S&P 500 as market breadth weakens. Here’s why SPY and QQQ investors may face hidden concentration risks.